These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37986385)

  • 21. Head-to-head comparison of prostatic urethral lift and water vapor thermal therapy for the treatment of symptomatic benign prostatic hyperplasia: a real-life study.
    Baboudjian M; Fourmarier M; Gondran-Tellier B; Pradere B; Userovici M; Alegorides C; Barry Delongchamps N
    Int Urol Nephrol; 2021 Sep; 53(9):1757-1763. PubMed ID: 34052957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimally invasive connective water vapor energy method for benign prostatic hyperplasia.
    Çakıroğlu B
    Urologia; 2024 May; 91(2):298-305. PubMed ID: 38069654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients' Perspectives on Attributes While Choosing Minimally Invasive Surgery for Benign Prostatic Hyperplasia Procedures: Experience from Men Undergoing Water Vapor Thermal Therapy.
    Rojanasarot S; Cutone B; Durand K; Zorn KC; Chughtai B; Bhojani N; Elterman DS
    J Endourol; 2023 May; 37(5):575-580. PubMed ID: 36762936
    [No Abstract]   [Full Text] [Related]  

  • 24. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostatic Artery Embolization Using 100-300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up.
    Ayyagari R; Powell T; Staib L; Chapiro J; Raja A; Bhatia S; Chai T; Schoenberger S; Devito R
    J Vasc Interv Radiol; 2020 Jan; 31(1):99-107. PubMed ID: 31771896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary results of a national multicenter study on the treatment of LUTS secondary to benign prostatic hyperplasia using the Rezūm® steam system.
    Fernández-Guzmán E; Asensio Matas A; Capape Poves V; Rioja Zuazu J; Garrido Abad P; Martínez-Salamanca JI; Quintana Franco LM; Justo-Quintas J; Romero-Otero J; Domínguez-Esteban M
    Actas Urol Esp (Engl Ed); 2022 Jun; 46(5):310-316. PubMed ID: 35570100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.
    McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
    J Sex Med; 2016 Jun; 13(6):924-33. PubMed ID: 27129767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-Year Outcomes of the Prospective, Randomized Controlled Rezūm System Study: Convective Radiofrequency Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
    McVary KT; Roehrborn CG
    Urology; 2018 Jan; 111():1-9. PubMed ID: 29122620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    McVary KT; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Pliskin M; Beahrs JR; Prall D; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Tadros NN; Gange SN; Roehrborn CG
    J Urol; 2021 Sep; 206(3):715-724. PubMed ID: 33872051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do Patients Treated with Water Vapor Therapy and Meeting Randomized Clinical Trial Criteria Have Better Urinary and Sexual Outcomes Than an Unselected Cohort?
    Cindolo L; Campobasso D; Conti E; Uricchio F; Franzoso F; Maruzzi D; Viola L; Varvello F; Balsamo R; Ferrari G; Morselli S; Siena G
    J Endourol; 2023 Mar; 37(3):323-329. PubMed ID: 36453237
    [No Abstract]   [Full Text] [Related]  

  • 32. Rezūm water vapor therapy for the treatment of patients with urinary retention and permanent catheter dependence secondary to benign prostate hyperplasia: a systematic review of the literature.
    Spinos T; Katafigiotis I; Leotsakos I; Grivas N; Zabaftis C; Ermidis D; Sfoungaristos S; Karavitakis M
    World J Urol; 2023 Feb; 41(2):413-420. PubMed ID: 36534152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rezum Therapy for Benign Prostatic Hyperplasia: Dubai's Initial Experience.
    Rowaiee R; Akhras A; Lakshmanan J; Sikafi Z; Janahi F
    Cureus; 2021 Sep; 13(9):e18083. PubMed ID: 34692298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Madersbacher S; Roehrborn CG; Oelke M
    BJU Int; 2020 Sep; 126(3):317-326. PubMed ID: 32599656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large, Multi-Center, Prospective Registry of Rezūm Water Vapor Therapy for Benign Prostatic Hyperplasia.
    Elterman D; Bhojani N; Vannabouathong C; Chughtai B; Zorn KC
    Urology; 2022 Jul; 165():261-267. PubMed ID: 35182585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rezūm therapy for ≥80-mL benign prostatic enlargement: a large, multicentre cohort study.
    Elterman D; Bhojani N; Vannabouathong C; Chughtai B; Zorn KC
    BJU Int; 2022 Oct; 130(4):522-527. PubMed ID: 35466513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Darson MF; Alexander EE; Schiffman ZJ; Lewitton M; Light RA; Sutton MA; Delgado-Rodriguez C; Gonzalez RR
    Res Rep Urol; 2017; 9():159-168. PubMed ID: 28861405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience.
    Mollengarden D; Goldberg K; Wong D; Roehrborn C
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):379-385. PubMed ID: 29282358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study.
    McVary KT; Rogers T; Roehrborn CG
    Urology; 2019 Apr; 126():171-179. PubMed ID: 30677455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system.
    De la Cuadra-Grande A; Rioja-Zuazu J; Domínguez-Esteban M; Torres E; Blissett R; Woodward E; Oyagüez I; Fernández-Arjona M
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jun; 23(5):499-510. PubMed ID: 36897833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.